
Glimpen MP 1mg/500mg/15mg Tablet SR
Marketer
Alencure Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimpen MP 1mg/500mg/15mg Tablet SR
Metformin/Glimepiride/Pioglitazone extended-release tablets (1mg/500mg/15mg) offer a combined approach to managing elevated blood glucose. This medication, used alongside a healthy diet and regular exercise, aids in better blood sugar regulation for adults with type 2 diabetes. It enhances insulin effectiveness, contributing to lower blood sugar. Dosage and frequency should strictly adhere to your physician's instructions. Take this medication with food to minimize digestive discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in that case, skip the missed dose and resume your regular regimen. Never double the dose. Excessive intake can result in dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia; consistent blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed before treatment begins. Limit alcohol consumption as it may heighten the likelihood of adverse effects.
Uses of Glimpen MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimpen MP 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimpen MP 1mg/500mg/15mg Extended-Release tablets with a meal.
Common Side effects of Glimpen MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimpen MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimpen MP 1mg/500mg/15mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medication with food.
How Glimpen MP 1mg/500mg/15mg Tablet SR works:
Glimpen MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimpen MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimpen MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Glimpen MP 1mg/500mg/15mg SR tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimpen MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimpen MP 1mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Glimpen MP 1mg/500mg/15mg SR tablets. Dosage modification may be necessary; seek medical advice before use. Glimpen MP 1mg/500mg/15mg SR tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimpen MP 1mg/500mg/15mg Tablet SR :
Should you forget to take a Glimpen MP 1mg/500mg/15mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimpen MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
